PUBLIC CITIZEN for PUBLIC CITIZEN
What was lobbied
11 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
NAFTA renegotiation,
| Lobbyist | Covered position, as disclosed |
|---|---|
| LORI WALLACH | — |
Taxation/Internal Revenue Code TAX
Oppose Johhson Amendment repeal, Oppose HR1 (Tax Reform), Wall Street Tax/Financial Transaction tax, opposing tax breaks for the rich and corporations, opposing House and Senate tax bills, opposing tax cuts and Jobs act,
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN ELAINE HARLEY | — |
| EMILY PETERSON CASSIN | — |
Banking BAN
HR 790-Return to Prudent Banking Act of 2017, S 881- 21st Century Glass-Steagall Act of 2017, Rep. Waters bill on breaking up banks, HR 477-Small Business, Mergers, Acquisitions and Brokerage Simplification Act of 2017, HR 1116-TAILOR Act of 2017, HR 1585-Fair Investment Opportunities for Professional Experts Act, HR 1645-Fostering Innovation Act of 2017, S 82/HR 399-Stop subsidizing Multi-million dollar corporate Business Act, HR 1153-Mortgage choice act of 2017, HR 3093-Investor, clarity and bank Purity Act, HR 3221-Seeing access to Affordable Mortgages Act, S 2155-Economic Growth, Regulatory relief & consumer protection act, HR 2219-End banking for Human Traffickers act of 2017, HR 2319-Consumer Financial Choice and Capital Markets Protection Act of 2017, Protect the CFPB, Dodd Frank, SEC nominee,
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA JEAN GILBERT | — |
| BARTLETT NAYLOR | — |
Civil Rights/Civil Liberties CIV
Protect the CFPB's forced arbitration regulation, employment arbitration, sexual harassment issues/civil justice, CFPB arbitration rule, HR 732-Settlement Slush Funds Act, Civil Justice bills, negotiated rulemaking/arbitration, SEC issues,
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA JEAN GILBERT | — |
| REMINGTON GREGG | — |
Health Issues HCR
Single Payer health care, S 771/HR 1776-The improving access to affordable medications act,
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHANNA DEVINE | — |
| EAGAN KEMP | — |
Consumer Issues/Safety/Products CSP
Regulatory reform, Push back on the RAA and other OIRA reform, keeping poison bill riders out of the budget, Robocalling rulemaking
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA JEAN GILBERT | — |
| REMINGTON GREGG | — |
| AMIT NARANG | — |
Government Issues GOV
Strengthening/codifying Office of Government Ethics, Trump Inaugural Committee surplus funds, S 1989/HR 4077-Honest Ads Act, S 625-Foreign Agents Registration Modernization and Enforcement Act, S 2039/GR 4170-Strengthening FARA, OGE rulemaking on executive branch defense funds, WE The People Package, Johnson Amendment defense, Protecting the Mueller investigation, SEC political disclosure, Freedom of Information act improvements, incorporation transparency,
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA JEAN GILBERT | — |
| SUSAN ELAINE HARLEY | — |
| CRAIG HOLMAN | — |
Financial Institutions/Investments/Securities FIN
Challenge the forced arbitration rule, investor protector issues,
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA JEAN GILBERT | — |
Budget/Appropriations BUD
Keeping poison bill riders out of the budget, amendments to Senate budget vote-a-rama
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA JEAN GILBERT | — |
| SUSAN ELAINE HARLEY | — |
Labor Issues/Antitrust/Workplace LBR
Federal Heat stress legislation, S 585/HR 3042-Whistle-blower protection act, HR 2229-All Circuit Review act, Safe patient handling legislation, HR 4303-Offshore Oil & Gas worker Whistle-blower Protection Act, HR 3989-USA Liberty act, HR 4396-The member and employee training and oversight on congress act (ME TOO), Poultry Inspection Line Speeds,
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHANNA DEVINE | — |
Pharmacy PHA
S 771/HR1776-Improving access to affordable prescription drugs act, S 2011/HR 4138-Medicare Price Negotiation Act of 2017, S 252-Medicare Drug Savings Act of 2017, S 1369/HR 2974-Stop Price Gouging Act, S 124-Preserve access to affordable generics act, HR 4117-Competitive DRUGS Act of 2017, S 974/HR 2212-CREATES act of 2017, HR 2051-FAST generics Act of 2017, S 495-Medicare Innovation Prize Fund Act, S 1131.HR 2439-FAIR Drug Pricing act, HR 4116-Transparent Drug Pricing Act of 2017, S 1509-Orphan Products extension accelerating cures and treatments, HR 1223-OPEN act, S 1390-Stronger Patriots Act of 2017, S 1827-KIDS Act of 2017, HR 1628-American Health care act of 2017, HR 3921-Healthy KIDS Act, HR 4116-Transparent drug pricing act of 2017, Bipartisan Health Care Stabilization Act of 2017, biologic market exclusivity, inter partes review, direct to consumer advertising, Over-the-counter Monograph Safety Innovation and Reform act of 2017, Azar HHS nomination,
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN KNIEVEL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.